These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 16470116

  • 1. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
    Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S, ANRS HC02 - Ribavic Study team.
    AIDS; 2006 Feb 28; 20(4):525-31. PubMed ID: 16470116
    [Abstract] [Full Text] [Related]

  • 2. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.
    Antivir Ther; 2008 Feb 28; 13(8):1057-65. PubMed ID: 19195331
    [Abstract] [Full Text] [Related]

  • 3. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
    Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D, Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA).
    Aliment Pharmacol Ther; 2007 Dec 28; 26(11-12):1489-98. PubMed ID: 17903235
    [Abstract] [Full Text] [Related]

  • 4. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ.
    J Infect Dis; 2005 Dec 01; 192(11):1943-9. PubMed ID: 16267765
    [Abstract] [Full Text] [Related]

  • 5. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.
    Clin Infect Dis; 2006 Apr 01; 42(7):1032-9. PubMed ID: 16511772
    [Abstract] [Full Text] [Related]

  • 6. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
    Bani-Sadr F, Barange K, Daoud F, Jacomet C, Bicart-See A, Rosenthal E, Cacoub P, Pol S, Perronne C, Carrat F, ANRS HC02 - Ribavic Study Team.
    HIV Med; 2009 Aug 01; 10(7):417-21. PubMed ID: 19490173
    [Abstract] [Full Text] [Related]

  • 7. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
    Gaslightwala I, Bini EJ.
    J Hepatol; 2006 Jun 01; 44(6):1026-32. PubMed ID: 16618518
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P, French National Agency for Research on AIDS, Viral Hepatitis-HC02-Ribavic Study Team.
    Clin Infect Dis; 2008 Mar 01; 46(5):768-74. PubMed ID: 18248298
    [Abstract] [Full Text] [Related]

  • 10. Hepatic steatosis in Iranian patients with chronic hepatitis C.
    Minakari M, Sameni FK, Shalmani HM, Molaee M, Zali MR.
    Med Princ Pract; 2008 Mar 01; 17(2):126-30. PubMed ID: 18287796
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.
    Am J Gastroenterol; 2003 May 01; 98(5):1150-4. PubMed ID: 12809841
    [Abstract] [Full Text] [Related]

  • 12. [ANRS HC 02 RIBAVIC: impact of steatosis in HIV-HCV co-infection].
    Pol S.
    Gastroenterol Clin Biol; 2009 Mar 01; 33 Suppl 2():S110-2. PubMed ID: 19375038
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.
    Monto A, Dove LM, Bostrom A, Kakar S, Tien PC, Wright TL.
    Hepatology; 2005 Aug 01; 42(2):310-6. PubMed ID: 16025515
    [Abstract] [Full Text] [Related]

  • 15. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
    Hézode C, Zafrani ES, Roudot-Thoraval F, Costentin C, Hessami A, Bouvier-Alias M, Medkour F, Pawlostky JM, Lotersztajn S, Mallat A.
    Gastroenterology; 2008 Feb 01; 134(2):432-9. PubMed ID: 18242211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
    Machado MV, Oliveira AG, Cortez-Pinto H.
    Hepatology; 2010 Jul 01; 52(1):71-8. PubMed ID: 20578130
    [Abstract] [Full Text] [Related]

  • 18. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G.
    Hepatology; 2001 Jun 01; 33(6):1358-64. PubMed ID: 11391523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
    Macías J, Mira JA, López-Cortés LF, Santos I, Girón-González JA, González-Serrano M, Merino D, Hernández-Quero J, Rivero A, Merchante N, Trastoy M, Carrillo-Gómez R, Arizcorreta-Yarza A, Gómez-Mateos J, Pineda JA.
    Antivir Ther; 2006 Jun 01; 11(7):839-46. PubMed ID: 17302246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.